#Blueprint pharma full

#Blueprint pharma full

Compare Standard and Premium Digital here.Īny changes made can be done at any time and will become effective at the end of the trial period, allowing you to retain full access for 4 weeks, even if you downgrade or cancel. Joining Blueprint Medicines means joining a diverse team relentlessly focused on helping people live longer, healthier livesworking each day with talented, driven and diverse individuals, who are all truly empowered to move ideas forward, think critically. You may also opt to downgrade to Standard Digital, a robust journalistic offering that fulfils many user’s needs. Blueprint MedicinesTechnology Fast 500 2021 RecipientAwarded by Deloitte LLP. If you’d like to retain your premium access and save 20%, you can opt to pay annually at the end of the trial. If you do nothing, you will be auto-enrolled in our premium digital monthly subscription plan and retain complete access for $69 per month.įor cost savings, you can change your plan at any time online in the “Settings & Account” section. Blueprint Medicines patient-focused site is an online community inform, empower and engage people living with systemic mastocytosis and those who support them. For a full comparison of Standard and Premium Digital, click here.Ĭhange the plan you will roll onto at any time during your trial by visiting the “Settings & Account” section.

Premium Digital includes access to our premier business column, Lex, as well as 15 curated newsletters covering key business themes with original, in-depth reporting. Standard Digital includes access to a wealth of global news, analysis and expert opinion. During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages.